Sort
326,823 grants matching “clinical trial”
Maternal vitamin C supplementation to decrease effects of smoking during pregnancy on infant lung function and health:Follow-up of 2 randomized trials and association with changes in DNA methylation
$2,106,606Cynthia T McEvoy · Oregon Health & Science University · UH3 · FY2019 · OD
PREVENTABLE Trial Implementation Phase
$2,106,576Karen P Alexander · Duke University · U19 · FY2025 · AG
Cardiovascular Regenerative Medicine
$2,106,550Douglas Eugene Vaughan · Northwestern University At Chicago · P01 · FY2014 · HL
Immunopathogenesis of acute and early HIV infection
$2,106,243Fred Valentine · New York University School Of Medicine · P01 · FY2008 · AI
North American Star Consortium
$2,106,066Philippe Bedard · University Health Network · UM1 · FY2023 · CA
Novel Insights Into Cerebral Ischemic Pathophysiology In Humans
$2,106,046Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,106,043Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Center for Pre-Clinical Cancer Research
$2,105,965Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2022 · GM
Clinical Core
$2,105,743Paul A. Newhouse · Vanderbilt University Medical Center · P20 · FY2022 · AG
Pragmatic Trial of Acupuncture for Chronic Low Back Pain in Older Adults
$2,105,544Lynn Larson Debar · Kaiser Foundation Research Institute · UH3 · FY2022 · AT
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,105,511Steven Mark Albelda · University Of Pennsylvania · P01 · FY2018 · CA
New Surgical Approaches For The Management Of Malignant Melanoma
$2,105,174Donald L Morton · Saint John'S Cancer Institute · P01 · FY2011 · CA
NK Cells, Their Receptors and Unrelated Donor Transplant
$2,105,144Jeffrey S Miller · University Of Minnesota · P01 · FY2009 · CA
Determine genotypic, phenotypic and evolutionary trajectories of treatment resistance to radiotherapy.
$2,105,127Priyanka Gopal · Northwestern University At Chicago · R01 · FY2025 · CA
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,104,992Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$2,104,975Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Immunotherapeutic Modulation of Peanut Allergy
$2,104,893Robert A Wood · Icahn School Of Medicine At Mount Sinai · U19 · FY2012 · AI
Alzheimer Disease Research Center
$2,104,821Helena Chang Chui · University Of Southern California · P50 · FY2014 · AG
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia
$2,104,654Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R33 · FY2023 · HL
Johns Hopkins-Tufts Trial Innovation Center
$2,104,577Daniel F Hanley · Johns Hopkins University · U24 · FY2021 · TR
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
$2,104,537Louis M Weiner · Georgetown University · P30 · FY2024 · CA
KwaZulu-Natal Clinical Trials Unit
$2,104,487Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2023 · AI
Repurposing FDA-approved oxytocin to treat opioid-induced respiratory depression
$2,104,389David Mendelowitz · George Washington University · UG3 · FY2025 · DA
Papillomavirus Virion Proteins and Vaccines
$2,104,241John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
TREATMENT RESEARCH CENTER--BEHAVIORAL PHARMACOLOGY
$2,104,139Johns Hopkins University · P50 · FY2002 · DA